The Clorox Company trades at a 17x forward P/E, 20% below the S&P 500, but I see fair value closer to $80 per share. CLX boasts strong brands, competitive margins, and a history of shareholder returns ...
The Clorox Company is rated 'Hold' with a 12-month price target of $120, implying a 10% upside excluding dividends. CLX faces headwinds from ERP transition, declining sales, and margin pressure, but ...